Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Use of regulatory T cells for GvHD prophylaxis and therapy in Europe

Closed Survey/Study

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Federico Simonetta

LA-DP Immunopeptidome Divergence Predicts CD4⁺ T-Cell Alloreactivity and Outcome of Hematopoietic Cell Transplantation

Études rétrospectives

Leucémie Myéloïde Aiguë (LMA)

Leucémie Aiguë Lymphoblastique (LAL)

Syndrome Myélodysplasique (MDS) ou MDS/MPN

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Peter van Balen & Liesbeth de Wreede

Real-World Use of Post-Transplant Cyclophosphamide (PTCy) for Graft-Vs-Host-Disease (GVHD) Prophylaxis in Transplant Centers

Toutes les maladies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Outcomes of patients over 70 years treated with brexucabtagene autoleucel for relapsed refractory mantle cell lymphoma: a study from the CTIWP of EBMT

Retrospective Studies

Other myeloid or lymphoid malignancies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Characteristics and outcomes of extramedullary myeloma receiving CAR-T cell therapy

Retrospective Studies

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Chronic Malignancies Working Party (CMWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Tomas Jelinek/Nico Gagelmann

Nutritional Care Practices during CAR-T Cell Treatment in Adult Patients

Closed Survey/Study

Nursing Research Committee

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Paolo Pedrazzoli

Outcomes after anti-BCMA CAR T-cells for multiple myeloma, a Retrospective analysis on behalf of the CTIWP and CMWP of the EBMT

Études rétrospectives

Myélome multiple (MM) ou autre dyscrasies plasmocytaires (PCD)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Chronic Malignancies Working Party (CMWP)

Type de traitement

Investigateur principal

IDWP-CTIWP: Survey on vaccination strategy in CAR-T patients

Toutes les maladies

Infectious Diseases Working Party (IDWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Agnieszka Piekarska

Survey on fertility procedures and outcomes for patients treated with CAR-T cell therapy

Closed Survey/Study

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Giorgio Orofino

CAR-T in elderly patients

Études rétrospectives

Lymphome non hodgkinien (LNH)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Vanderson Rocha

Disease-specificity effects of HLA mismatching effects in unrelated HCT under with PTCy-based GvHD prophylaxis

Études rétrospectives

Leucémie Aiguë Lymphoblastique (LAL)

Leucémie Myéloïde Aiguë (LMA)

Chronic Lymphocytic Leukaemia (CLL)

Leucémie Myéloïde Chronique (LMC)

Chronic Lymphocytic Leukaemia (CLL)

Syndrome Myélodysplasique (MDS) ou MDS/MPN

Autres tumeurs malignes myéloïdes ou lymphoïdes

Myélome multiple (MM) ou autre dyscrasies plasmocytaires (PCD)

Lymphome non hodgkinien (LNH)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Acute Leukemia Working Party (ALWP)

Type de traitement

Allogénique - Non apparentée

Investigateur principal

HLA Mismatch Frequencies in Unrelated Hematopoietic Cell Transplantation

Retrospective Studies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Allogeneic - Unrelated

Investigateur principal

Esteban Arrieta Bolaños